---

Martin VanTrieste

Immediate Past Chair, Parenteral Drug Association 

“I would like to see a significant increase in R&D productivity, so that significant therapies get to patients faster. There are two things that most R&D organizations can do to be more effective: one, embrace productivity enhancing techniques, such as lean, which their manufacturing colleagues have embraced, and R&D professionals have resisted; two, R&D professionals must kill bad projects faster, so that valuable resources can be redeployed on projects with greater potential for success.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018